Vaccines (May 2022)

B Cell Responses upon Human Papillomavirus (HPV) Infection and Vaccination

  • Priya R. Prabhu,
  • Joseph J. Carter,
  • Denise A. Galloway

DOI
https://doi.org/10.3390/vaccines10060837
Journal volume & issue
Vol. 10, no. 6
p. 837

Abstract

Read online

Infection with human papillomavirus (HPV) is the necessary cause of cervical cancer. Availability of vaccines against HPV makes it a highly preventable disease. HPV vaccines act through type-specific neutralizing antibodies produced by antigen-specific plasma cells known as long-lived plasma cells (LLPC). However, just as any other vaccine, success of HPV vaccine is attributed to the immunologic memory that it builds, which is largely attained through generation and maintenance of a class of B cells named memory B cells (Bmem). Both LLPCs and Bmems are important in inducing and maintaining immune memory and it is therefore necessary to understand their role after HPV vaccination to better predict outcomes. This review summarizes current knowledge of B-cell responses following HPV vaccination and natural infection, including molecular signatures associated with these responses.

Keywords